Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study.

Shinichi KomiyamaTsuyoki KugimiyaKaneyuki Kubushiro

Published in: Journal of surgical oncology (2018)

In Japanese patients with advanced ovarian cancer, bevacizumab + NAC followed by IDS is an acceptable strategy. Further investigation of its prognostic effect is warranted.

Keyphrases

neoadjuvant chemotherapy
locally advanced
metastatic colorectal cancer
lymph node
sentinel lymph node
minimally invasive
coronary artery bypass
transcription factor
squamous cell carcinoma
rectal cancer
radiation therapy
early stage
coronary artery disease